Search
Enovis Corp
ENOVAdd to Watchlist
29.150USD
-0.140-0.48%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.68BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Enovis Corp is 8.55, ranking 27 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 49.00, with a high of 58.00 and a low of 33.00.
Analyst Rating
Based on
13
analysts
Buy
Current Rating
41.917
Target Price
+43.80%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Enovis Corp
ENOV
13
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Enovis Corp's expected revenue for the next quarter?
Enovis Corp's expected revenue is 582.54M.
What is Enovis Corp's price target?
Analysts forecast that Enovis Corp's price target is USD 49.00, with the highest forecast at USD 58.00 and the lowest forecast at USD 33.00.
How have Enovis CorpENOV's recent earnings per share performed?
The market expectation was USD -0.15, while Enovis CorpENOV's earnings per share (EPS) for the previous quarter was USD -9.10. EPS for the next quarter is expected at USD 0.85.
What is the analyst rating for Enovis Corp?
Based on the ratings of Enovis Corp's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.